前列腺切除术后瘤床放疗后复发模式:C-11胆碱PET/CT识别
本研究评估C-11胆碱PET/CT在前列腺切除术后放疗后生化失败患者中的分期和复发模式识别作用。结果可能有助于探讨术后择区淋巴结照射策略。
要点
- 多数生化失败患者复发位于前列腺切除术后放疗野外。
- 多数复发部位为淋巴结且位于腹主动脉分叉以下。
- 结果可能为术后择区淋巴结照射策略提供数据。
核心结论
- 使用C-11胆碱PET/CT评估生化失败患者,多数复发位于前列腺切除术后放疗野外。
- 多数复发部位为淋巴结且位于腹主动脉分叉以下。
研究设计与样本
- 纳入2008至2015年前列腺切除术后放疗后生化失败并接受C-11胆碱PET/CT的患者。
- 复发按与照射瘤床野关系分为野外(OOF)、野边缘(EOF,复发位于<45-Gy等剂量线内)和野内(IF,复发位于≥45-Gy等剂量线内)。
主要发现
- C-11胆碱PET/CT时中位PSA为3.1 ng/mL(IQR 1.9-5.6)。
- 放疗至生化失败中位间隔24个月(IQR 10-46),生化失败至CholPET识别复发中位15个月(IQR 7-28)。
- 20例(49%)经组织学确认复发,其余经治疗反应确认。
- 5例(12%)为IF复发,10例(24%)为EOF复发(中位剂量10 Gy;IQR 5-30 Gy),36例(88%)为OOF复发。
- 10例为组合失败:6例(15%)EOF/OOF,4例(10%)IF/OOF。
临床怎么用
- C-11胆碱PET/CT可用于前列腺切除术后放疗后生化失败患者的复发部位评估。
- 多数复发位于放疗野外且为腹主动脉分叉以下淋巴结,提示可探讨择区淋巴结照射策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate C-11 choline positron emission tomography/computed tomography (CholPET) in staging and determining patterns of recurrence in prostate cancer patients with rising prostate-specific antigen levels after prostatectomy radiation therapy (RT). METHODS AND MATERIALS: The study includes patients with biochemical failure after postprostatectomy RT who underwent CholPET between 2008 and 2015. Patient and disease characteristics were examined in relation to sites of recurrence. All RT dosimetry records were reviewed, and recurrences were mapped on a representative computed tomography dataset with their relationship relative to the irradiated fossa field as out of field (OOF), edge of field (EOF; recurrence within <45-Gy isodose lines), or in field (IF; recurrence within ≥45-Gy isodose lines). RESULTS: Forty-one patients were identified with 121 sites of recurrence (median 2 sites; interquartile range [IQR], 1-4). The median prostate-specific antigen level at CholPET was 3.1 (IQR, 1.9-5.6) ng/mL. Median interval from RT to biochemical failure was 24 (IQR, 10-46) months, with recurrence identified on CholPET at a median of 15 (IQR, 7-28) months from biochemical failure. Histologic confirmation of recurrence was obtained in 20 patients (49%), with the remainder confirmed by treatment response. Five patients (12%) had IF recurrences, 10 patients (24%) had EOF recurrences (median dose 10 Gy; IQR, 5-30 Gy), and 36 patients (88%) had OOF recurrences. Ten patients had combination failures: 6 (15%) EOF/OOF and 4 (10%) IF/OOF. Fifty-seven recurrences (47%) were pelvic nodal sites inferior to the L5-S1 interspace, of which 52 (43%) were within a pelvic RT field. Eighty-one recurrences (67%) were nodal and inferior to the aortic bifurcation. CONCLUSIONS: Using CholPET, we found that the majority of patients evaluated for biochemical failure recurred outside of the postprostatectomy RT field. Furthermore, most recurrence sites were nodal and inferior to the aortic bifurcation. These results provide data that may be useful for examining strategies that include elective lymph node irradiation in postprostatectomy patients.
引用
- Parker WP, Evans JD, Stish BJ, et al. Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys. 2016. PMID: 28126302. doi:10.1016/j.ijrobp.2016.11.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。